Newsfeeds - Spark Newswire

1 minute read

Edwards’ Transcatheter Tricuspid Replacement System Shows Favorable Patient Outcomes

Today, 1:46 PM

â€‹â€‹â€‹â€‹Edwards Lifesciences Corporation (NYSE:EW) announced results from the TRISCEND study of its EVOQUE transcatheter tricuspid valve replacement system. Patients enrolled in…

1 minute read

Analyst Ratings

Expert Ratings For Edwards Lifesciences

By Benzinga Insights

Today, 1:46 PM

Edwards Lifesciences (NYSE:EW) has observed the following analyst ratings within the last quarter:

1 minute read

Edwards Lifesciences Says Delta Variant Drove Procedure Deferrals In Q3

By Vandana Singh

Today, 1:46 PM

Edwards Lifesciences Corp (NYSE:EW) reported Q3 earnings of $340.1 million, or $0.54 per share, ahead of the consensus of $0.53. Sales…

1 minute read

Credit Suisse Maintains Outperform on Edwards Lifesciences, Raises Price Target to $130

By Benzinga Newsdesk

Today, 1:46 PM

Credit Suisse analyst Matt Miksic maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $126 to $130.

4 minute read

The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug

By Shanthi Rexaline

Today, 1:46 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ALDX

1 minute read

Wells Fargo Maintains Equal-Weight on Edwards Lifesciences, Raises Price Target to $126

By Benzinga Newsdesk

Today, 1:46 PM

Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Equal-Weight and raises the price target from $115 to $126.

1 minute read

Raymond James Maintains Outperform on Edwards Lifesciences, Raises Price Target to $127

By Benzinga Newsdesk

Today, 1:46 PM

Raymond James analyst Jayson Bedford maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $122 to $127.

1 minute read

Earnings

Recap: Edwards Lifesciences Q3 Earnings

By Benzinga Insights

Today, 1:46 PM

Edwards Lifesciences (NYSE:EW) reported its Q3 earnings results on Wednesday, October 27, 2021 at 04:15 PM. Here's what investors need to know about the announcement.

1 minute read

Edwards Lifesciences Q3 EPS $0.54 Beats $0.53 Estimate, Sales $1.31B Miss $1.32B Estimate

By Benzinga Newsdesk

Today, 1:46 PM

Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.53 by 1.89 percent. This is a 5.88 percent increase over earnings of $0.51 per share from the

17 minute read

Earnings Scheduled For October 27, 2021

By Benzinga Insights

Today, 1:46 PM

Companies Reporting Before The Bell • McDonald's (NYSE:MCD) is expected to report quarterly earnings at $2.46 per share on revenue of $6.03 billion.

ACBI